Inventor · disambiguated record
Charles M. Perou
Also filed as: PEROU CHARLES · PEROU CHARLES M
17 granted patents·33 pending applications·124 citations·filing 1997–2023
92Inventor score
Files withGENECENTRIC THERAPEUTICS INC19UNIV NORTH CAROLINA7UNIV NORTH CAROLINA CHAPEL HILL6PEROU CHARLES M3UNIV UTAH RES FOUND2
Top patents by PatentIndex Score
50 records- 0193US8822153B2Molecular diagnosis and typing of lung cancer variantsHAYES DAVID N·Filed 2008·Granted Sep 2, 2014·51 cites·5 claims
- 0289US7118853B2Methods of classifying, diagnosing, stratifying and treating cancer patients and their tumorsUNIV LELAND STANFORD JUNIOR·Filed 2001·Granted Oct 10, 2006·33 cites·46 claims
- 0388US11851715B2Detecting cancer cell of originGENECENTRIC THERAPEUTICS INC·Filed 2022·Granted Dec 26, 2023·1 cites·7 claims
- 0486US10934595B2Methods for subtyping of lung adenocarcinomaGENECENTRIC THERAPEUTICS INC·Filed 2017·Granted Mar 2, 2021·4 cites·11 claims
- 0585US11739386B2Methods for determining response to PARP inhibitorsGENECENTRIC THERAPEUTICS INC·Filed 2018·Granted Aug 29, 2023·3 cites·9 claims
- 0685US9631239B2Method of classifying a breast cancer instrinsic subtypePEROU CHARLES M·Filed 2009·Granted Apr 25, 2017·8 cites·9 claims
- 0782US12195805B2Methods for subtyping of bladder cancerGENECENTRIC THERAPEUTICS INC·Filed 2019·Granted Jan 14, 2025·2 cites·13 claims
- 0882US11041214B2Methods for subtyping of lung squamous cell carcinomaGENECENTRIC THERAPEUTICS INC·Filed 2017·Granted Jun 22, 2021·2 cites·14 claims
- 0981US10829819B2Methods for typing of lung cancerGENECENTRIC THERAPEUTICS INC·Filed 2015·Granted Nov 10, 2020·3 cites·15 claims
- 1079US2023250484A1Gene expression profiles to predict breast cancer outcomesUNIV NORTH CAROLINA CHAPEL HILL·Filed 2023·Application pending·0 cites
- 1177US9066963B2Methods of treating breast cancer with anthracycline therapyPEROU CHARLES M·Filed 2012·Granted Jun 30, 2015·4 cites·12 claims
- 1276US2022213563A1Gene expression profiles to predict breast cancer outcomesUNIV NORTH CAROLINA CHAPEL HILL·Filed 2022·Application pending·0 cites
- 1374US9181588B2Methods of treating breast cancer with taxane therapyPEROU CHARLES M·Filed 2012·Granted Nov 10, 2015·5 cites·20 claims
- 1474US2023272476A1Nano46 genes and methods to predict breast cancer outcomeVERACYTE INC·Filed 2022·Application pending·0 cites
- 1574US2022243283A1Methods for typing of lung cancerGENECENTRIC THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1671US2022002820A1Methods for typing of lung cancerGENECENTRIC THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1771US2019264290A1Gene expression profiles to predict breast cancer outcomesUNIV NORTH CAROLINA CHAPEL HILL·Filed 2019·Application pending·0 cites
- 1870US2023395263A1Gene expression subtype analysis of head and neck squamous cell carcinoma for treatment managementGENECENTRIC THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1970US2020040407A1Gene expression profiles to predict breast cancer outcomesUNIV NORTH CAROLINA CHAPEL HILL·Filed 2019·Application pending·0 cites
- 2068US2021147948A1Methods for typing of lung cancerGENECENTRIC THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2166US12139765B2Methods for subtyping of lung squamous cell carcinomaGENECENTRIC THERAPEUTICS INC·Filed 2021·Granted Nov 12, 2024·0 cites·5 claims
- 2265US12139763B2Methods for subtyping of lung adenocarcinomaGENECENTRIC THERAPEUTICS INC·Filed 2021·Granted Nov 12, 2024·0 cites·5 claims
- 2365US2014087959A1Methods And Compositions Involving Intrinsic GenesUNIV WASHINGTON·Filed 2013·Application pending·0 cites
- 2464US2009299640A1Methods and Compositions Involving Intrinsic GenesUNIV UTAH RES FOUND·Filed 2006·Application pending·0 cites
- 2563US2020332368A1Nano46 genes and methods to predict breast cancer outcomeVERACYTE INC·Filed 2020·Application pending·0 cites
- 2662US10196687B2Molecular diagnosis and typing of lung cancer variantsUNIV NORTH CAROLINA CHAPEL HILL·Filed 2016·Granted Feb 5, 2019·0 cites·12 claims
- 2761US2021388449A1Detecting cancer cell of originGENECENTRIC THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2861US2015024399A1Molecular diagnosis and typing of lung cancer variantsUNIV NORTH CAROLINA·Filed 2014·Application pending·0 cites
- 2960US2016153051A1Gene expression profiles to predict breast cancer outcomesUNIV NORTH CAROLINA·Filed 2015·Application pending·0 cites
- 3060US2022415434A1Methods for cancer cell stratificationGARVAN INSTITUTE OF MEDICAL RES·Filed 2022·Application pending·0 cites
- 3160US2016168645A1Gene expression profiles to predict breast cancer outcomesUNIV NORTH CAROLINA·Filed 2015·Application pending·0 cites
- 3260US2019203296A1Methods for typing of lung cancerGENECENTRIC THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3357US2021074431A1Gene expression subtype analysis of head and neck squamous cell carcinoma for treatment managementGENECENTRIC THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3457US2017044618A1Methods and compositions involving intrinsic genesUNIV WASHINGTON·Filed 2016·Application pending·0 cites
- 3556US2010221722A1Methods for evaluating breast cancer prognosisUNIV NORTH CAROLINA·Filed 2008·Application pending·0 cites
- 3654US2024182984A1Methods for assessing proliferation and anti-folate therapeutic responseGENECENTRIC THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3754US2002115144A1Compositions for the diagnosis and treatment of chediak-higashi syndromeMILLENNIUM·Filed 2001·Application pending·0 cites
- 3852US2015344962A1Methods for evaluating breast cancer prognosisUNIV NORTH CAROLINA·Filed 2015·Application pending·0 cites
- 3950US2023243813A1Methods for selecting and treating cancer with fgfr3 inhibitorsGENECENTRIC THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4049US2021398612A1Detecting tumor mutation burden with rna substrateGENECENTRIC THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4148US2024018597A1DNA Copy Number Alterations (CNAs) to Determine Cancer PhenotypesUNIV NORTH CAROLINA CHAPEL HILL·Filed 2020·Application pending·0 cites
- 4245US2006040302A1Methods of classifying, diagnosing, stratifying and treating cancer patients and their tumorsBOTSTEIN DAVID·Filed 2005·Application pending·0 cites
- 4344US12006554B2Methods for subtyping of head and neck squamous cell carcinomaGENECENTRIC THERAPEUTICS INC·Filed 2018·Granted Jun 11, 2024·0 cites·15 claims
- 4443US2020392581A1Chemoendocrine score (ces) based on pam50 for breast cancer with positive hormone receptors with an intermediate risk of recurrenceGEICAM GRUPO ESPANOL DE INVESTIG EN CANCER DE MAMA·Filed 2017·Application pending·0 cites
- 4543US2008032293A1Housekeeping Genes And Methods For Identifying SameUNIV NORTH CAROLINA·Filed 2005·Application pending·0 cites
- 4641US2015072021A1Methods and Kits for Predicting Outcome and Methods and Kits for Treating Breast Cancer with Radiation TherapyBRITISH COLUMBIA CANCER AGENCY·Filed 2014·Application pending·0 cites
- 4739US5952223ACompositions for the diagnosis and treatment of Chediak-Higashi syndromeMILLENNIUM PHARMACEUTICALS·Filed 1997·Granted Sep 14, 1999·6 cites·20 claims
- 4839US2015252440A1Methods of Treating Breast Cancer with Anthracycline TherapyUNIV NORTH CAROLINA·Filed 2015·Application pending·0 cites
- 4935US6310182B1Compositions for the diagnosis and treatment of Chediak-Higashi syndromeMILLENNIUM PHARM INC·Filed 1999·Granted Oct 30, 2001·2 cites·12 claims
- 5035US2016017438A1Methods of treating breast cancer with taxane therapyUNIV UTAH RES FOUND·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Charles M. Perou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →